Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€522.40

€522.40

0.020%
0.1
0.020%
€547.55
 
23.08.24 / Tradegate WKN: 869561 / Symbol: UNH / Name: UnitedHealth / Stock / Healthcare Providers & Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

UnitedHealth Group Inc. Stock

With only a change of €0.10 (0.020%) the UnitedHealth Group Inc. price is nearly unchanged from yesterday.
The stock is one of the favorites of our community with 42 Buy predictions and 1 Sell predictions.
As a result the target price of 547 € shows a slightly positive potential of 4.71% compared to the current price of 522.4 € for UnitedHealth Group Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for UnitedHealth Group Inc. stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of UnitedHealth Group Inc. in the next few years

Pros
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of UnitedHealth Group Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
UnitedHealth Group Inc. 0.020% -0.324% 2.211% 15.960% 9.633% 44.250% 152.306%
Centene Corp. 0.570% -0.960% 17.361% 19.744% 5.045% 27.582% 65.710%
Humana Inc. -0.750% -0.818% -11.333% -28.874% -23.748% -10.655% 21.013%
Cigna Corp. 1.140% 1.803% 2.082% 21.850% 16.765% 78.796% 129.763%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

When evaluating the financials of UnitedHealth Group (UNH), it becomes apparent that this company stands as a formidable entity within the Healthcare Providers & Services industry. The metrics and trends presented in the financial statements, alongside the ratios provided, paint a picture of robust growth prospects, operational efficiency, and a sound balance sheet. However, not all appears pristine; there are nuances worth exploring that highlight both strengths and potential pitfalls.

Pros of UnitedHealth's Financials

Strong Revenue Streams: UnitedHealth has consistently shown impressive revenue growth, with total revenues amounting to approximately $385.44 billion over the last twelve months. The company's ability to generate significant top-line revenue is indicative of its market strength and wide-ranging service offerings.

Comments

Prediction Buy
Perf. (%) -0.63%
Target price 533.673
Change
Ends at 19.08.25

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $591.00 price target on the stock.
Ratings data for UNH provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 2.19%
Target price 544.252
Change
Ends at 23.07.25

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $591.00 price target on the stock.
Ratings data for UNH provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.66%
Target price 623.832
Change
Ends at 19.07.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target raised by analysts at UBS Group AG from $640.00 to $680.00. They now have a "buy" rating on the stock.
Ratings data for UNH provided by MarketBeat
Show more

News

Bull Market Buys: 2 Growth Stocks to Own for the Long Run: https://g.foolcdn.com/editorial/images/784953/astonished-shocked-coffee-newspaper.jpg
Bull Market Buys: 2 Growth Stocks to Own for the Long Run

Investors who buy stocks through both bull and bear markets are the ones who tend to benefit more in the long term because they are growing their portfolios consistently. But a bull market does seem

Got $5,000? These 3 Growth Stocks Are Incredibly Cheap Buys Right Now: https://g.foolcdn.com/editorial/images/784061/a-couple-of-investors-looking-at-a-series-of-charts.jpg
Got $5,000? These 3 Growth Stocks Are Incredibly Cheap Buys Right Now

Buying quality growth stocks doesn't have to involve paying an enormous premium. There are some solid, underrated companies worth buying right now that don't trade at egregious valuations. While

This Ultra-High-Yield Dividend Stock Hits Yet Another Setback: https://g.foolcdn.com/editorial/images/784193/a-person-looking-at-a-red-stock-chart-on-a-tablet.jpg
This Ultra-High-Yield Dividend Stock Hits Yet Another Setback

Medical Properties Trust (NYSE: MPW) has been struggling because of tenant issues, which has made it more difficult for the real estate investment trust (REIT) to manage its large debt load. The